期刊文献+

多模式磁共振在指导小范围急性脑卒中静脉溶栓治疗中的应用价值 被引量:6

Application value of multimode MRI in guiding intravenous thrombolytic therapy of small scale ACI
下载PDF
导出
摘要 目的用多模式磁共振探讨影响急性脑梗死静脉溶栓治疗预后的解剖学因素。方法回顾性分析169例接受rt PA静脉溶栓治疗的急性小范围脑梗死患者的影像学资料。以美国国立卫生研究院率中评分量表(National Institute of Health Stroke Scale,NIHSS)进行入院评分,以90 d时的改良Rankin量表(m RS)评分作为疗效指标,分析比较不同部位、不同干预间隔(OTT)(<270 min、≥270 min)情况下急性小范围脑梗死的愈后。结果 (1)不同发病部位小范围梗死发病前NIHSS评分差异无统计学意义(P>0.05)。不同发病部位3个月后m RS评分差异有统计学意义(P<0.05),发病部位位于端脑及基底节区的患者显著疗效比例高于另外2组。(2)OTT对小范围梗死的预后影响比较差异无统计学意义(P>0.05)。结论不同发病部位的小范围脑梗死愈后不同。不同干预间隔对小范围梗死的预后没有显著影响。 Objective To investigate the anatomic factors affecting the prognosis of acute cerebral infarction (ACI) with in- travenous thrombolytie therapy by using multimode Mill. Methods Photographic data of 169 ACI cases treated with rtPA intravenous thrombolytic therapy were retrospectively analyzed. With NIHSS used as the admission scores and mRS scores at day 90 as the curative effect index, analyses were made on the prognosis of small scale ACI at different parts and different intervention intervals (DII) ( 〈 270 min, ≥270 rain). Results ( 1 ) There were no significant differences in the NIHSS scores of the patients with small scale infarction at different affected sites ( P 〉 0.05 ). After 3 months, statistical significance could be seen in mRS scores at different affected sites ( P 〉 0.05 ). The proportion of obvious efficacy for the patients with the affected sites at end-brain and basal ganglion region was obviously higher than that of the other 2 groups. (2) Statistical significance could neither be seen in the effect of DII on the prognosis of small scale ACI ( P 〉 0.05 ). Conclusion Outcomes of different cerebral infarction were varied at different affected' sites. Different interven- tion interval (DII: 〈270 min, ≥ 270 min) seemed to have no significant effect on the prognosis of the small area infarction.
出处 《海军医学杂志》 2016年第1期36-39,共4页 Journal of Navy Medicine
关键词 急脑性梗死 磁共振成像 血栓溶解疗法 Acute cerebral infarction Magnetic resonance imaging (MRI) Thrombolytic therapy
  • 相关文献

参考文献12

二级参考文献73

  • 1[1]Wityk RJ, Pessin MS, Kaplan RF, et al. Serial assessment of acute stroke using the NIH Stroke Scale. Stroke, 1994, 25:362-365.
  • 2[2]Tan CC, Eckardt KU, Firth JD, et al. Feedback modlation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol, 1992, 263:474-481.
  • 3[3]Yu X, Shacka JJ, Eells JB, et al. Erythropoietin receptor signalling is required for normal brain development. Development, 2002, 129:505-510.
  • 4[4]Siren AL, Knerlich F, Poser W, et al. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (Berl), 2001, 101:271-276.
  • 5[5]Bernaudin M, Marti HH, Roussel S, et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab, 1999, 19:643-651.
  • 6[6]Morishita E, Masuda S, Nagao M, et al. Erythropoietin receptor is expressed in rat hippocampal and cerebral contical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death.Neuroscience, 1997, 76:105-116.
  • 7[7]Calapai G, Marciano MC, Corica F, et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation.Eur J Pharmacol, 2000, 401:349-356.
  • 8[8]Yoshimura A, Misawa H. Physiology and function of the erythropoietin receptor. Curr Opin Hematol, 1998, 5:171-176.
  • 9[9]Shingo T, Sorokan ST, Shimazaki T, et al. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci, 2001, 21:9733-9743.
  • 10[10]Ribatti D, Presta M, Vacca A, et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood, 1999, 93:2627-2636.

共引文献51

同被引文献74

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部